Neurology Minute podcast

The Amyloid Hypothesis for Alzheimer's disease and Aducanumab

0:00
1:57
Retroceder 15 segundos
Avanzar 15 segundos

Dr. Erik Musiek discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer's disease.

Otros episodios de "Neurology Minute"